{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:47:20Z","timestamp":1793933240520,"version":"4.8.0"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007514","name":"University of Pisa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007514","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004434","name":"Universit\u00e0 degli Studi di Firenze","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Republic of Serbia Ministry of Education Science and Technological Development","doi-asserted-by":"publisher","award":["451-03-66\/2024-03\/200007"],"award-info":[{"award-number":["451-03-66\/2024-03\/200007"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ejmech.2025.117364","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T11:58:13Z","timestamp":1738756693000},"page":"117364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Anticancer activity promoted by ligand diversity in diiron thiocarbyne complexes"],"prefix":"10.1016","volume":"287","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8632-1718","authenticated-orcid":false,"given":"Ekatarina","family":"Mihajlovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9276-0095","authenticated-orcid":false,"given":"Lorenzo","family":"Biancalana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4906-9880","authenticated-orcid":false,"given":"Marija","family":"Moji\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9848-6859","authenticated-orcid":false,"given":"Sanja","family":"Jela\u010da","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4857-9819","authenticated-orcid":false,"given":"Lorenzo","family":"Chiaverini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0739-0518","authenticated-orcid":false,"given":"Stefano","family":"Zacchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9509-9098","authenticated-orcid":false,"given":"Sanja","family":"Mijatovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8006-5079","authenticated-orcid":false,"given":"Danijela","family":"Maksimovi\u0107-Ivani\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3683-8708","authenticated-orcid":false,"given":"Fabio","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117364_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102925","article-title":"Cisplatin: the first metal based anticancer drug","volume":"88","author":"Ghosh","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117364_bib2","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00280-016-2976-z","article-title":"Platinum-based drugs: past, present and future","volume":"77","author":"Dilruba","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117364_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1012093","article-title":"Platinum drugs-related safety profile: the latest five-year analysis from FDA adverse event reporting system data","volume":"12","author":"Feng","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2025.117364_bib4","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1039\/C8DT00838H","article-title":"The side effects of platinum-based chemotherapy drugs: a review for chemists","volume":"47","author":"Oun","year":"2018","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2025.117364_bib5","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1021\/acs.chemrestox.9b00204","article-title":"Advances in toxicological research of the anticancer drug cisplatin","volume":"32","author":"Qi","year":"2019","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejmech.2025.117364_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2021.214210","article-title":"What blocks more anticancer platinum complexes from experiment to clinic: major problems and potential strategies from drug design perspectives","volume":"449","author":"Peng","year":"2021","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.117364_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.chempr.2019.10.013","article-title":"Classi\ufb01cation of metal-based drugs according to their mechanisms of action","volume":"6","author":"Boros","year":"2020","journal-title":"Chem"},{"key":"10.1016\/j.ejmech.2025.117364_bib8","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1021\/cr900134a","article-title":"Application of metal coordination chemistry to explore and manipulate cell biology","volume":"109","author":"Haas","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.117364_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ddtec.2019.06.001","article-title":"Organometallic compounds in drug discovery: past, present and future","volume":"37","author":"Ching Ong","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2025.117364_bib10","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1021\/cr400135x","article-title":"Advances in copper complexes as anticancer agents","volume":"114","author":"Santini","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.117364_bib11","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/cplu.201600413","article-title":"Anticancer RuII and RhIII piano\u2010stool complexes that are histone deacetylase inhibitors","volume":"81","author":"Cross","year":"2016","journal-title":"ChemPlusChem"},{"key":"10.1016\/j.ejmech.2025.117364_bib12","doi-asserted-by":"crossref","first-page":"12888","DOI":"10.1039\/D0SC04082G","article-title":"Metallodrugs are unique: opportunities and challenges of discovery and development","volume":"11","author":"Anthony","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2025.117364_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.chempr.2019.10.013","article-title":"Classi\ufb01cation of metal-based drugs according to their mechanisms of action","volume":"6","author":"Boros","year":"2020","journal-title":"Chem"},{"key":"10.1016\/j.ejmech.2025.117364_bib14","series-title":"Iron Metabolism: from Molecular Mechanisms to Clinical Consequences","first-page":"22","article-title":"The essential role of iron in biology","author":"Crichton","year":"2016"},{"key":"10.1016\/j.ejmech.2025.117364_bib15a","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/nyas.13008","article-title":"Iron and cancer: recent insights","volume":"1368","author":"Manz","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejmech.2025.117364_bib15b","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev-nutr-082117-051732","article-title":"Iron and cancer","volume":"38","author":"Torti","year":"2018","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.ejmech.2025.117364_bib16","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1021\/om400446y","article-title":"A new age for iron: antitumoral ferrocenes","volume":"32","author":"Braga","year":"2013","journal-title":"Organometallics"},{"key":"10.1016\/j.ejmech.2025.117364_bib17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41570-017-0066","article-title":"The medicinal chemistry of ferrocene and its derivatives","volume":"1","author":"Patra","year":"2017","journal-title":"Nat. Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.117364_bib18","article-title":"Ferrocenes in medicinal chemistry; a personal perspective","volume":"905","author":"Sansook","year":"2019","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.ejmech.2025.117364_bib19","article-title":"Ferroptosis-enhanced cancer immunity by a ferrocene-appended iridium(III) diphosphine complex","volume":"61","author":"Wang","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.117364_bib20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ccr.2016.02.008","article-title":"Ferrocenyl-nucleobase complexes: synthesis, chemistry and applications","volume":"317","author":"Kowalski","year":"2016","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.117364_bib21","article-title":"Ferrocene-modified imidazoles: one-pot oxalyl chloride-assisted synthesis, HPLC enantiomeric resolution, and in vivo antitumor effects","volume":"36","author":"Rodionov","year":"2022","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.ejmech.2025.117364_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/aoc.5276","article-title":"Administration of ferrocene-modified amino acids induces changes in synaptic transmission in the CA1 area of the hippocampus","volume":"34","author":"Rodionov","year":"2020","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.ejmech.2025.117364_bib23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11172-017-1711-1","article-title":"Ferrocenemodified amino acids: synthesis and in vivo bioeffects on hippocampus","volume":"66","author":"Rodionov","year":"2017","journal-title":"Russ. Chem. Bull. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.117364_bib24","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1039\/D0CC03012K","article-title":"Metal\u2013organic complex-based chemodynamic therapy agents for cancer therapy","volume":"56","author":"Hwang","year":"2020","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2025.117364_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2022.214897","article-title":"Redox regulation and its emerging roles in cancer treatment","volume":"475","author":"Zhang","year":"2023","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.117364_bib26","doi-asserted-by":"crossref","first-page":"10477","DOI":"10.1039\/D4SC02002B","article-title":"How does ferrocene correlate with ferroptosis? Multiple approaches to explore ferrocene-appended GPX4 inhibitors as anticancer agents","volume":"15","author":"Li","year":"2024","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2025.117364_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2020.213658","article-title":"Multifaceted chemical behaviour of metallocene (M = Fe, Os) quinone methides. Their contribution to biology","volume":"430","author":"Vessi\u00e8res","year":"2021","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.117364_bib28","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1021\/acs.jmedchem.8b00077","article-title":"Lipophilic e\ufb03ciency as an important metric in drug design","volume":"61","author":"Johnson","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117364_bib29","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s11095-010-0303-7","article-title":"Lipophilicity a.nd its relationship with passive drug permeation","volume":"28","author":"Liu","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejmech.2025.117364_bib30","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/hep.26208","article-title":"High lipophilicity and high daily dose of oral medications are associated with signi\ufb01cant risk for drug-induced liver injury","volume":"58","author":"Chen","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2025.117364_bib31","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ccr.2009.07.022","article-title":"Bridging vinylalkylidene transition metal complexes","volume":"254","author":"Busetto","year":"2010","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.117364_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2021.214203","article-title":"Aminocarbyne ligands in organometallic chemistry","volume":"449","author":"Biancalana","year":"2021","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.117364_bib33","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1021\/cr940270y","article-title":"Hydrocarbyl ligand transformations on heterobimetallic complexes","volume":"107","author":"Ritleng","year":"2007","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.117364_bib34","first-page":"99","article-title":"Role of a redox-active ligand close to a dinuclear activating framework. Philippe kalck. Modes of cooperative effects in dinuclear complexes","volume":"vol. 70","author":"Elleouet","year":"2022"},{"key":"10.1016\/j.ejmech.2025.117364_bib35","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41570-020-00226-5","article-title":"Bimetallic cooperation across the periodic table","volume":"4","author":"Campos","year":"2020","journal-title":"Nat. Rev. Chem"},{"key":"10.1016\/j.ejmech.2025.117364_bib36","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1021\/acs.organomet.4c00050","article-title":"Skeletal rearrangement of a \u03bc\u2212\u03b72:\u03b74-Hexatrienyl ligand at a diruthenium site via a \u03bc\u2212\u03b75-ruthenacyclohexadienyl intermediate","volume":"23","author":"Takao","year":"2024","journal-title":"Organometallics"},{"key":"10.1016\/j.ejmech.2025.117364_bib37","doi-asserted-by":"crossref","first-page":"7729","DOI":"10.1038\/s41467-024-52116-9","article-title":"Water-catalyzed iron-molybdenum carbyne formation in bimetallic acetylene transformation","volume":"15","author":"Zhai","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117364_bib38","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1039\/D3QI00157A","article-title":"Diruthenium(II,III) paddlewheel complexes: effects of bridging and axial ligands on anticancer properties","volume":"10","author":"Tolbatov","year":"2023","journal-title":"Inorg. Chem. Front."},{"key":"10.1016\/j.ejmech.2025.117364_bib39","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1002\/cmdc.201600315","article-title":"Insights into the in vitro anticancer effects of diruthenium-I","volume":"11","author":"Koceva-Chy\u0142a","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.117364_bib40","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1002\/ejic.201800659","article-title":"Constructing organometallic architectures from aminoalkylidyne diiron complexes","author":"Marchetti","year":"2018","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117364_bib41","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1039\/a902793i","article-title":"Generation of substrate-binding sites by electrochemical reduction of cis-[Fe2(cp)2(\u03bc-SMe)2(MeCN)(L)]2+ (L = CO or MeCN). Reactivity of the sites toward CO and tBuNC. Crystal structure of [Fe2(cp)2(\u03bc-SMe)2(CO)(MeCN)][BF4]2\u00b7CH2Cl2","author":"Madec","year":"1999","journal-title":"J. Chem. Soc. Dalton Trans."},{"key":"10.1016\/j.ejmech.2025.117364_bib42","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1021\/acs.organomet.9b00681","article-title":"Exploring the anticancer potential of diiron bis-cyclopentadienyl complexes with bridging hydrocarbyl ligands: behavior in aqueous media and in vitro cytotoxicity","volume":"39","author":"Agonigi","year":"2020","journal-title":"Organometallics"},{"key":"10.1016\/j.ejmech.2025.117364_bib43","doi-asserted-by":"crossref","first-page":"10169","DOI":"10.1002\/chem.202101048","article-title":"Easily available, amphiphilic diiron cyclopentadienyl complexes exhibit in vitro anticancer activity in 2D and 3D human cancer cells through redox modulation triggered by CO release","volume":"27","author":"Biancalana","year":"2021","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2025.117364_bib44","doi-asserted-by":"crossref","DOI":"10.1093\/mtomcs\/mfac096","article-title":"The choice of \u03bc-vinyliminium ligand substituents is key to optimize the antiproliferative activity of related diiron complexes","volume":"15","author":"Campanella","year":"2023","journal-title":"Metallomics"},{"key":"10.1016\/j.ejmech.2025.117364_bib45","doi-asserted-by":"crossref","first-page":"14801","DOI":"10.1002\/chem.201902885","article-title":"Anticancer potential of diiron vinyliminium complexes","volume":"25","author":"Rocco","year":"2019","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2025.117364_bib46","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1016\/j.ica.2008.01.001","article-title":"Thiocarbonyl, thiocarbyne and thiocarbene ligands in di-and polynuclear complexes","volume":"361","author":"Busetto","year":"2008","journal-title":"Inorg. Chim. Acta."},{"key":"10.1016\/j.ejmech.2025.117364_bib47","doi-asserted-by":"crossref","first-page":"7553","DOI":"10.1021\/acs.jmedchem.4c00377","article-title":"FETPY: a diiron(I) thio\u2013carbyne complex with prominent anticancer activity in vitro and in vivo","volume":"67","author":"Mihajlovi\u0107","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117364_bib48","doi-asserted-by":"crossref","first-page":"10742","DOI":"10.1021\/acs.chemrev.1c00143","article-title":"Medicinal chemistry of isocyanides","volume":"121","author":"Massarotti","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.117364_bib49","doi-asserted-by":"crossref","first-page":"12004","DOI":"10.1021\/ja039394v","article-title":"The hydrophilic phosphatriazaadamantane ligand in the development of H2 production electrocatalysts: iron hydrogenase model complexes","volume":"126","author":"Mejia-Rodriguez","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117364_bib50","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ccr.2009.08.006","article-title":"Coordination chemistry of 1,3,5-triaza-7-phosphaadamantane (PTA) and derivatives. Part II. The quest for tailored ligands, complexes and related applications","volume":"254","author":"Bravo","year":"2010","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.117364_bib51","article-title":"Recent considerations in the application of RAPTA-C for cancer treatment and perspectives for its combination with immunotherapies","volume":"2","author":"Rausch","year":"2019","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ejmech.2025.117364_bib52a","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinorgbio.2014.03.002","article-title":"Influence of PPh3 moiety in the anticancer activity of new organometallic ruthenium complexes","volume":"136","author":"S\u00e1ez","year":"2014","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2025.117364_bib52b","doi-asserted-by":"crossref","first-page":"10043","DOI":"10.1021\/acs.chemrev.7b00042","article-title":"Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications","volume":"117","author":"Zielonka","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.117364_bib53","unstructured":"IR (MeCN): \u03a5\u0342\/cm-1 = 2120 (C\u2261N), 1811 (\u03bc-CO). This intermediate compound was not isolated."},{"key":"10.1016\/j.ejmech.2025.117364_bib54","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1021\/om500502h","article-title":"Coupling of isocyanide and \u03bc-aminocarbyne ligands in diiron complexes promoted by hydride addition","volume":"33","author":"Marchetti","year":"2014","journal-title":"Organometallics"},{"key":"10.1016\/j.ejmech.2025.117364_bib55","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jorganchem.2018.01.030","article-title":"Bonding and structural features of metal-metal bonded homo- and hetero-dinuclear complexes supported by unsaturated hydrocarbon ligands","volume":"869","author":"Tsurugi","year":"2018","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.ejmech.2025.117364_bib56","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ccr.2017.07.001","article-title":"Activation of alkynes by diphosphine- and \u03bc-phosphido-spanned heterobimetallic complexes","volume":"350","author":"Knorr","year":"2017","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.117364_bib57a","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1021\/acs.organomet.5b00515","article-title":"C\u2013N coupling of isocyanide ligands promoted by acetylide addition to diiron aminocarbyne complexes","volume":"34","author":"Marchetti","year":"2015","journal-title":"Organometallics"},{"key":"10.1016\/j.ejmech.2025.117364_bib57b","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0022-328X(02)01652-2","article-title":"Dithiocarbamate derivatives of \u03bc-thiocarbyne complexes: synthesis and X-ray molecular structure of [Fe2(\u03bc-CS)(\u03bc-CSMe)(\u03bc-S2CNMe2)Cp2]","volume":"659","author":"Albano","year":"2002","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.ejmech.2025.117364_bib58","unstructured":"Previously reported compounds sharing a {Fe2(\u03b75-C5R5)2(\u03bc2-CSR\u2019)} fragment (R, R\u2019: any substituent) without terminal carbonyl ligands are [Fe2Cp2(\u03bc-CO)(CNMe)2(\u03bc-CSMe)]PF6, [Fe2Cp2(\u03bc-CO)(CNXyl)2(\u03bc-CSMe)]CF3SO3, [Fe2Cp2(\u03bc-CX)(NCMe)2(\u03bc-CSMe)]CF3SO3 (X = O, S) and [Fe2Cp2(\u03bc-CS)(\u03ba2S-\u03bc-S2CNMe2)(\u03bc-CSMe)] [57]. Sci-Finder (https:\/\/scifinder.cas.org),24\/08\/2023."},{"key":"10.1016\/j.ejmech.2025.117364_bib59","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1016\/j.jorganchem.2005.07.027","article-title":"Carbene ligands in diiron complexes","volume":"690","author":"Busetto","year":"2005","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.ejmech.2025.117364_bib60","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1021\/ic50218a033","article-title":"Substitution and S-alkylation reactions of thiocarbonyl-bridged Cp2Fe2(CO)3CS","volume":"20","author":"Quick","year":"1981","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117364_bib61","unstructured":"According to Cahn\u2013Ingold\u2013Prelog Priority Rules, the E Isomers of 2-4 Feature the SMe Group on the Same Side of the Isocyanide Ligand, the E Isomers of 5-7 Feature the SMe Group on the Same Side of the Carbonyl Ligand."},{"key":"10.1016\/j.ejmech.2025.117364_bib62","series-title":"Reactivity of Bridging Thiocarbyne Complexes of Iron","author":"Schroeder","year":"1985"},{"key":"10.1016\/j.ejmech.2025.117364_bib63","first-page":"258","article-title":"NMR determination of the rotational barrier in N,N-dimethylacetamide","volume":"54","author":"Gasparro","year":"1977","journal-title":"J. Chem."},{"key":"10.1016\/j.ejmech.2025.117364_bib64","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1021\/om00012a001","article-title":"An unusual hydrogen migration from a cyclopentadienyl to a \u03bc-carbyne carbon in the reaction of grignard reagents with [Fe2(CO)2(cp)2(\u03bc-CO)(\u03bc-CSMe)]SO3CF3","volume":"14","author":"Albano","year":"1995","journal-title":"Organometallics"},{"key":"10.1016\/j.ejmech.2025.117364_bib65","doi-asserted-by":"crossref","first-page":"14554","DOI":"10.1021\/acs.inorgchem.8b02088","article-title":"Ubiquity of cis -halide \u2192 isocyanide direct interligand interaction in organometallic complexes","volume":"57","author":"Bartalucci","year":"2018","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117364_bib66","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117364_bib67","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.1039\/D2QI00534D","article-title":"When ferrocene and diiron organometallics meet: triiron vinyliminium complexes exhibit strong cytotoxicity and cancer cell selectivity","volume":"9","author":"Schoch","year":"2022","journal-title":"Inorg. Chem. Front."},{"key":"10.1016\/j.ejmech.2025.117364_bib68","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1517\/17460441003605098","article-title":"Lipophilicity in drug discovery","volume":"5","author":"Waring","year":"2010","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117364_bib69","article-title":"Carborane conjugates with ibuprofen, fenoprofen and flurbiprofen: synthesis, characterization, COX inhibition potential and in vitro activity","volume":"20","author":"Sonam","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.117364_bib70","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.3390\/ijms22147422","article-title":"A comparative analysis of the in vitro anticancer activity of iridium(III) {\u03b75-C5Me4R} complexes with variable R groups","volume":"22","author":"De Palo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117364_bib71","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.3390\/cells11172677","article-title":"Heterogeneity of the NIH3T3 fibroblast cell line","volume":"11","author":"Rahimi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2025.117364_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2023.112399","article-title":"Novel diphenyltin(IV) complexes with carboxylato N-functionalized 2-quinolone ligands: synthesis, characterization and in vitro anticancer studies","volume":"250","author":"Kasalovi\u0107","year":"2024","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2025.117364_bib73","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3390\/oxygen2040030","article-title":"RONS and oxidative stress: an overview of basic concepts","volume":"2","author":"Aranda-Rivera","year":"2022","journal-title":"Oxygen"},{"key":"10.1016\/j.ejmech.2025.117364_bib74","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1158\/0008-5472.CAN-20-1628","article-title":"Targeting mitochondrial iron metabolism suppresses tumor growth and metastasis by inducing mitochondrial dysfunction and mitophagy","volume":"81","author":"Sandoval-Acu\u00f1a","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.117364_bib75","doi-asserted-by":"crossref","first-page":"93502","DOI":"10.18632\/oncotarget.19548","article-title":"Nrf2 induces cisplatin resistance via suppressing the iron export related gene SLC40A1 in ovarian cancer cells","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2025.117364_bib76","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1172\/JCI115080","article-title":"Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation","volume":"87","author":"Parker","year":"1991","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2025.117364_bib77","article-title":"Molecular mechanisms of cisplatin resistance in ovarian cancer","volume":"11","author":"Jiang","year":"2023","journal-title":"Genes Dis"},{"key":"10.1016\/j.ejmech.2025.117364_bib78","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1021\/acs.accounts.9b00150","article-title":"Aconitases: non-redox iron-sulfur proteins sensitive to reactive species","volume":"52","author":"Castro","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2025.117364_bib79","doi-asserted-by":"crossref","first-page":"7897","DOI":"10.1021\/acs.inorgchem.2c00504","article-title":"Switching on cytotoxicity of water-soluble diiron organometallics, by UV irradiation","volume":"61","author":"Biancalana","year":"2022","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117364_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102124","article-title":"The potentials of carbon monoxide-releasing molecules in cancer treatment: an outlook from ROS biology and medicine","volume":"46","author":"Tien Vo","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2025.117364_bib81a","doi-asserted-by":"crossref","first-page":"607","DOI":"10.14348\/molcells.2017.0151","article-title":"Autophagy is pro-senescence when seen in close-up, but anti-senescence in long-shot","volume":"40","author":"Kwon","year":"2017","journal-title":"Mol. Cell."},{"key":"10.1016\/j.ejmech.2025.117364_bib81b","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41581-022-00601-z","article-title":"Cellular senescence: the good, the bad and the unknown","volume":"18","author":"Huang","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ejmech.2025.117364_bib82","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.biotechadv.2018.04.001","article-title":"Naturally occurring compounds in differentiation based therapy of cancer","volume":"36","author":"Mijatovi\u0107","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ejmech.2025.117364_bib83","article-title":"A signature of enhanced lipid metabolism, lipid peroxidation and aldehyde stress in therapy-induced senescence","volume":"3","author":"Flor","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2025.117364_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155876","article-title":"Daphnetin induces ferroptosis in ovarian cancer by inhibiting NAD(P)H:Quinone oxidoreductase 1 (NQO1)","volume":"132","author":"Ma","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2025.117364_bib85","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3389\/fonc.2020.00951","article-title":"Ultraviolet radiation and melanomagenesis: from mechanism to immunotherapy","volume":"10","author":"Sun","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2025.117364_bib86","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.drudis.2016.07.007","article-title":"Quality guidelines for oral drug candidates: dose, solubility and lipophilicity","volume":"21","author":"Bayliss","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2025.117364_bib87a","doi-asserted-by":"crossref","first-page":"C35","DOI":"10.1016\/S0022-328X(00)90997-5","article-title":"Synthesis of thiocarbonyl-bridged (\u03b75-C5H5)2Fe2(CO)3(CS) and crystal structure of an S-alkylated derivative","volume":"148","author":"Wagner","year":"1978","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.ejmech.2025.117364_bib87b","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0022-328X(00)91216-6","article-title":"Synthesis and cleavage reactions of thiocarbonyl-bridged Cp2Fe2(CO)3CS, and preparation of the carbene complexes CpFe(CO)C(N2C2H6)SnPh3 and [CpFe(CO)2C(OMe)2]PF6","volume":"160","author":"Quick","year":"1978","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.ejmech.2025.117364_bib87c","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/9780470132593.ch47","article-title":"Dicarbonyl(\u03b75-Cyclopentadienyl)(Thiocarbonyl)Iron(1+) trifluoromethane-sulfonate(1\u2013) and dicarbonyl(\u03b75-cyclopentadienyl)[(Methylthio)Thiocarbonyl]Iron","volume":"28","author":"Dombek","year":"1990","journal-title":"Inorg. Synth."},{"key":"10.1016\/j.ejmech.2025.117364_bib88a","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1021\/om100106e","article-title":"NMR chemical shifts of trace impurities: common laboratory solvents, organics, and gases in deuterated solvents relevant to the organometallic chemist","volume":"29","author":"Fulmer","year":"2010","journal-title":"Organometallics"},{"key":"10.1016\/j.ejmech.2025.117364_bib88b","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1351\/pac200173111795","article-title":"NMR nomenclature. Nuclear spin properties and conventions for chemical shifts (IUPAC Recommendations 2001)","volume":"73","author":"Harris","year":"2001","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.ejmech.2025.117364_bib89","series-title":"Spectragryph - Optical Spectroscopy Software","author":"Menges","year":"2016"},{"key":"10.1016\/j.ejmech.2025.117364_bib90","doi-asserted-by":"crossref","first-page":"10387","DOI":"10.1039\/C7DT02049J","article-title":"Half-sandwich iron(II) complexes with protic acyclic diaminocarbene ligands: synthesis, deprotonation and metalation reactions","volume":"46","author":"Ruiz","year":"2017","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2025.117364_bib91","series-title":"SADABS-2008\/1 - Bruker AXS Area Detector Scaling and Absorption Correction","author":"Sheldrick","year":"2008"},{"key":"10.1016\/j.ejmech.2025.117364_bib92","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. C"},{"key":"10.1016\/j.ejmech.2025.117364_bib93a","article-title":"OECD guidelines for testing of chemicals","volume":"107","year":"1995","journal-title":"OECD"},{"key":"10.1016\/j.ejmech.2025.117364_bib93b","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/qsar.19880070304","article-title":"The measurement of partition coefficients","volume":"7","author":"Dearden","year":"1988","journal-title":"Quant. Struct.-Act. Relat."},{"key":"10.1016\/j.ejmech.2025.117364_bib94","unstructured":"Methanol Was Used as a Co-solvent to Prepare Solutions Suitable for 1H NMR Analysis (> 3 mmol\u2219L-1); the Methanol\/water Ratio Was Selected with Respect to the Water Solubility of the Compound."},{"key":"10.1016\/j.ejmech.2025.117364_sref88","unstructured":"Calculated Using the Formula pD = pH\u2217 + 0.4, where pH\u2217 Is the Value Measured for H2O-Calibrated pH-Meter."},{"key":"10.1016\/j.ejmech.2025.117364_bib95a","series-title":"pH Measurements","author":"Westcott","year":"1978"},{"key":"10.1016\/j.ejmech.2025.117364_bib95b","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1021\/ac60260a013","article-title":"Use of the glass electrode in deuterium oxide and the relation between the standardized pD (paD) scale and the operational pH in heavy water","volume":"40","author":"Covington","year":"1968","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejmech.2025.117364_bib96","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1039\/D3MD00344B","article-title":"Exploring the potential of tamoxifen-based copper(II) dichloride in breast cancer therapy","volume":"14","author":"Kazimir","year":"2023","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117364_bib97","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1158\/0008-5472.CAN-14-0247","article-title":"Say No to DMSO: dimethylsulfoxide inactivates cisplatin, carboplatin, and other platinum complexes","volume":"74","author":"Hall","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.117364_bib98","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jorganchem.2016.12.010","article-title":"In\ufb02uence of the dissolution solvent on the cytotoxicity of octahedral cationic Ir(III) hydride complexes","volume":"839","author":"Huang","year":"2017","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.ejmech.2025.117364_bib99","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.3390\/nano12213767","article-title":"Mesoporous silica nanoparticles enhance the anticancer efficacy of platinum(IV)-Phenolate conjugates in breast cancer cell lines","volume":"12","author":"Predarska","year":"2022","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ejmech.2025.117364_bib100","article-title":"Isonimesulide and its carborane analogues as isoform-selective COX inhibitors and antitumor agents","volume":"6","author":"Useini","year":"2023","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ejmech.2025.117364_bib101","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.phrs.2016.01.011","article-title":"Versatile antitumor potential of isoxanthohumol: enhancement of paclitaxel activity in vivo","volume":"105","author":"Krajnovi\u0107","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2025.117364_bib102","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1039\/c2mt20150j","article-title":"Melanoma tumor inhibition by tetrachlorido(O,O'-dibutyl-ethylenediamine-N,N'-di-3-propionate)platinum(IV) complex: in vitro and in vivo investigation","volume":"4","author":"Maksimovi\u0107-Ivani\u0107","year":"2012","journal-title":"Metallomics"},{"key":"10.1016\/j.ejmech.2025.117364_bib103","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1039\/c5mt00312a","article-title":"Behavior of platinum (IV) complexes in models of tumor hypoxia: cytotoxicity, compound distribution and accumulation","volume":"8","author":"Schreiber-Brynzak","year":"2016","journal-title":"Metallomics"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425001291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425001291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T06:03:58Z","timestamp":1759298638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425001291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":113,"alternative-id":["S0223523425001291"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117364","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticancer activity promoted by ligand diversity in diiron thiocarbyne complexes","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117364"}}